Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength

REFERENCES

• Egerman MA, Glass DJ. 2014. Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol 49:59–68. https://doi.org/10.3109/10409238.2013.857291.
   PubMed Web of Science ®Google Scholar
• Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395–403. https://doi.org/10.1016/S1097-2765(04)00211-4.
   PubMed Web of Science ®Google Scholar
• Sandri M. 2014. Regulation and involvement of the ubiquitin ligases in muscle atrophy. Free Radic Biol Med 75(Suppl 1):S4. https://doi.org/10.1016/j.freeradbiomed.2014.10.833.
   PubMedGoogle Scholar
• Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3:1009–1013. https://doi.org/10.1038/ncb1101-1009.
   PubMed Web of Science ®Google Scholar
• Babula P, Masarik M, Adam V, Eckschlager T, Stiborova M, Trnkova L, Skutkova H, Provaznik I, Hubalek J, Kizek R. 2012. Mammalian metallothioneins: properties and functions. Metallomics 4:739–750. https://doi.org/10.1039/c2mt20081c.
   PubMed Web of Science ®Google Scholar
• Kimura T, Kambe T. 2016. The functions of metallothionein and ZIP and ZnT transporters: an overview and perspective. Int J Mol Sci 17:336. https://doi.org/10.3390/ijms17030336.
   PubMed Web of Science ®Google Scholar
• Lindeque JZ, Levanets O, Louw R, van der Westhuizen FH. 2010. The involvement of metallothioneins in mitochondrial function and disease. Curr Protein Pept Sci 11:292–309. https://doi.org/10.2174/138920310791233378.
   PubMed Web of Science ®Google Scholar
• Ruttkay-Nedecky B, Nejdl L, Gumulec J, Zitka O, Masarik M, Eckschlager T, Stiborova M, Adam V, Kizek R. 2013. The role of metallothionein in oxidative stress. Int J Mol Sci 14:6044–6066. https://doi.org/10.3390/ijms14036044.
   PubMed Web of Science ®Google Scholar
• Krizkova S, Ryvolova M, Hrabeta J, Adam V, Stiborova M, Eckschlager T, Kizek R. 2012. Metallothioneins and zinc in cancer diagnosis and therapy. Drug Metab Rev 44:287–301. https://doi.org/10.3109/03602532.2012.725414.
   PubMed Web of Science ®Google Scholar
• Mocchegiani E, Costarelli L, Basso A, Giacconi R, Piacenza F, Malavolta M. 2013. Metallothioneins, ageing and cellular senescence: a future therapeutic target. Curr Pharm Des 19:1753–1764. https://doi.org/10.2174/1381612811319090022.
   PubMed Web of Science ®Google Scholar
• Bolognin S, Cozzi B, Zambenedetti P, Zatta P. 2014. Metallothioneins and the central nervous system: from a deregulation in neurodegenerative diseases to the development of new therapeutic approaches. J Alzheimers Dis 41:29–42.
   PubMedGoogle Scholar
• Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ. 2005. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280:2737–2744. https://doi.org/10.1074/jbc.M407517200.
   PubMed Web of Science ®Google Scholar
• Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL. 2004. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18:39–51. https://doi.org/10.1096/fj.03-0610com.
   PubMed Web of Science ®Google Scholar
• Urso ML, Scrimgeour AG, Chen YW, Thompson PD, Clarkson PM. 2006. Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components. J Appl Physiol (1985) 101:1136–1148. https://doi.org/10.1152/japplphysiol.00180.2006.
   PubMed Web of Science ®Google Scholar
• Hyldahl RD, O'Fallon KS, Schwartz LM, Clarkson PM. 2010. Knockdown of metallothionein 1 and 2 does not affect atrophy or oxidant activity in a novel in vitro model. J Appl Physiol (1985) 109:1515–1523. https://doi.org/10.1152/japplphysiol.00588.2010.
   PubMedGoogle Scholar
• DeRuisseau LR, Recca DM, Mogle JA, Zoccolillo M, DeRuisseau KC. 2009. Metallothionein deficiency leads to soleus muscle contractile dysfunction following acute spinal cord injury in mice. Am J Physiol Regul Integr Comp Physiol 297:R1795–R1802. https://doi.org/10.1152/ajpregu.00263.2009.
   PubMedGoogle Scholar
• Maret W. 2011. Redox biochemistry of mammalian metallothioneins. J Biol Inorg Chem 16:1079–1086. https://doi.org/10.1007/s00775-011-0800-0.
   PubMedGoogle Scholar
• Kambe T, Tsuji T, Hashimoto A, Itsumura N. 2015. The Physiological, biochemical, and molecular roles of zinc transporters in zinc homeostasis and metabolism. Physiol Rev 95:749–784. https://doi.org/10.1152/physrev.00035.2014.
   PubMed Web of Science ®Google Scholar
• Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, Kurosaki T, Yamashita S, Tokunaga M, Nishida K, Hirano T. 2007. Zinc is a novel intracellular second messenger. J Cell Biol 177:637–645. https://doi.org/10.1083/jcb.200702081.
   PubMed Web of Science ®Google Scholar
• Haase H, Maret W. 2003. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp Cell Res 291:289–298. https://doi.org/10.1016/S0014-4827(03)00406-3.
   PubMedGoogle Scholar
• Lynch CJ, Patson BJ, Goodman SA, Trapolsi D, Kimball SR. 2001. Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR. Am J Physiol Endocrinol Metab 281:E25–E34.
   PubMedGoogle Scholar
• Bellomo E, Hogstrand C, Maret W. 2014. Redox and zinc signalling pathways converging on protein tyrosine phosphatases. Free Radic Biol Med 75(Suppl 1):S9. https://doi.org/10.1016/j.freeradbiomed.2014.10.851.
   PubMedGoogle Scholar
• Mocchegiani E, Giacconi R, Malavolta M. 2008. Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol Med 14:419–428. https://doi.org/10.1016/j.molmed.2008.08.002.
   PubMed Web of Science ®Google Scholar
• Li Y, Maret W. 2009. Transient fluctuations of intracellular zinc ions in cell proliferation. Exp Cell Res 315:2463–2470. https://doi.org/10.1016/j.yexcr.2009.05.016.
   PubMedGoogle Scholar
• Hirano T, Murakami M, Fukada T, Nishida K, Yamasaki S, Suzuki T. 2008. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv Immunol 97:149–176. https://doi.org/10.1016/S0065-2776(08)00003-5.
   PubMed Web of Science ®Google Scholar
• Ibebunjo C, Chick JM, Kendall T, Eash JK, Li C, Zhang Y, Vickers C, Wu Z, Clarke BA, Shi J, Cruz J, Fournier B, Brachat S, Gutzwiller S, Ma Q, Markovits J, Broome M, Steinkrauss M, Skuba E, Galarneau JR, Gygi SP, Glass DJ. 2013. Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia. Mol Cell Biol 33:194–212. https://doi.org/10.1128/MCB.01036-12.
   PubMed Web of Science ®Google Scholar
• Russell ST, Siren PM, Siren MJ, Tisdale MJ. 2009. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1,2,6-triphosphate. Cancer Chemother Pharmacol 64:517–527. https://doi.org/10.1007/s00280-008-0899-z.
   PubMed Web of Science ®Google Scholar
• Maret W, Krezel A. 2007. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med 13:371–375.
   PubMed Web of Science ®Google Scholar
• Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ. 2004. Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24:9295–9304. https://doi.org/10.1128/MCB.24.21.9295-9304.2004.
   PubMed Web of Science ®Google Scholar
• Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD. 1994. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A 91:584–588. https://doi.org/10.1073/pnas.91.2.584.
   PubMed Web of Science ®Google Scholar
• Michalska AE, Choo KH. 1993. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci U S A 90:8088–8092. https://doi.org/10.1073/pnas.90.17.8088.
   PubMed Web of Science ®Google Scholar
• Beattie JH, Wood AM, Newman AM, Bremner I, Choo KH, Michalska AE, Duncan JS, Trayhurn P. 1998. Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci U S A 95:358–363. https://doi.org/10.1073/pnas.95.1.358.
   PubMedGoogle Scholar
• Glass DJ. 2010. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol 346:267–278.
   PubMed Web of Science ®Google Scholar
• Basualto-Alarcón C, Jorquera G, Altamirano F, Jaimovich E, Estrada M. 2013. Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy. Med Sci Sports Exerc 45:1712–1720. https://doi.org/10.1249/MSS.0b013e31828cf5f3.
   PubMed Web of Science ®Google Scholar
• Lee NK, Skinner JP, Zajac JD, MacLean HE. 2011. Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation. Am J Physiol Endocrinol Metab 301:E172–E179. https://doi.org/10.1152/ajpendo.00094.2011.
   PubMed Web of Science ®Google Scholar
• Bongers KS, Fox DK, Kunkel SD, Stebounova LV, Murry DJ, Pufall MA, Ebert SM, Dyle MC, Bullard SA, Dierdorff JM, Adams CM. 2015. Spermine oxidase maintains basal skeletal muscle gene expression and fiber size and is strongly repressed by conditions that cause skeletal muscle atrophy. Am J Physiol Endocrinol Metab 308:E144–E158. https://doi.org/10.1152/ajpendo.00472.2014.
   PubMed Web of Science ®Google Scholar
• Bodine SC, Furlow JD. 2015. Glucocorticoids and skeletal muscle. Adv Exp Med Biol 872:145–176. https://doi.org/10.1007/978-1-4939-2895-8_7.
   PubMed Web of Science ®Google Scholar
• Wray CJ, Mammen JM, Hershko DD, Hasselgren PO. 2003. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 35:698–705. https://doi.org/10.1016/S1357-2725(02)00341-2.
   PubMedGoogle Scholar
• Falduto MT, Czerwinski SM, Hickson RC. 1990. Glucocorticoid-induced muscle atrophy prevention by exercise in fast-twitch fibers. J Appl Physiol (1985) 69:1058–1062.
   PubMedGoogle Scholar
• Applied Biosystems. 2001. ABI user bulletin UB #2: ABI Prism 7700 sequence detection system. Relative quantitation of gene expression. Applied Biosystems, Foster City, CA.
   Google Scholar
• Verbanac D, Milin C, Domitrovic R, Giacometti J, Pantovic R, Ciganj Z. 1997. Determination of standard zinc values in the intact tissues of mice by ICP spectrometry. Biol Trace Elem Res 57:91–96.
   PubMedGoogle Scholar